PATENT CLAIM ANALYSIS

Application Number: 16117107
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2018-12
Patent Classification: ["514", "341000"]

Abstract:
The present invention provides compounds of Formula (I): a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, a solvate thereof, wherein all of the variables are as defined herein. These compounds are monoacylglycerol acyltransferase type 2 (MGAT2) inhibitors which may be used as medicaments.

Claim (Index 5):
A compound of Formula (IIa): or a stereoisomer, a tautomer, a pharmaceutically acceptable salt, a polymorph, a solvate or a hydrate thereof, wherein:\n R 1  is independently selected from: \n R 2  is independently selected from: CF 3  and CH 3 ; R 6  is independently selected from: halogen, C 1-4  alkyl substituted with 0-1 OH, C 1-4  alkoxy, C 1-4  haloalkoxy, CO(C 1-4  alkyl), and \u2014(CH 2 ) 0-1 \u2014C 3-4  cycloalkyl; R b  is independently selected from: \u2014(CH 2 ) 1-6 CF 3 , \u2014(CH 2 ) 1-4 CF 2 CF 3 , \u2014O(CH 2 ) 1-6 CF 3 , and \u2014O(CH 2 ) 1-4 CF 2 CF 3 ; R e  is, at each occurrence, independently selected from: C 1-4  alkyl, \u2014(CH 2 ) 1-6 CF 3 , and \u2014(CH 2 ) 0-1 \u2014C 3-4  cycloalkyl; and R g  is independently halogen.

Metadata:
- Claim Count in Document: 56.0
- Percentile: 96.0
- Lexical Diversity: 1.35714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15866871', '15123773', '15602515', '15618182', '15123791']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8324740610956567
- 35 USC 102 Novelty (BERT): 0.5689036917736017
- Combined Prediction Score: 0.8061170241634512
- Mean Citation Score: 398.53599
- Max Citation Score: 441.1919
- Similarity Product: 433.4895359649777

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test